Replication-deficient adenoviral vectors are one of the viral vectors that have been extensively used as recombinant cancer vaccines as they cause potent cell mediated (cytotoxic CD8 T cells responses) and humoral immune response against transgenes expressed by the adenoviral vectors (1). This evidence concerns the gene CD8A and cancer.